JPMorgan Chase Funding Inc.
CIK 1364743 · last filed 2025-10-24
JPMorgan Chase Funding Inc. is a corporate insider who has filed 24 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for SKYQ, was dated Oct 24, 2025. Across all open-market trades the lifetime net is +$7.3M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.0M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.05M
5
24
$7.29M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SKYQ | 10%+ Owner | 281,235 | $3.73 | $1.05M | $0 | 1 | 2025-10-24 |
| CANDELA CORP /DE/ (CLZR) Delisted | 10%+ Owner | 1,590,000 | — | — | $7.43M | 11 | 2008-10-10 |
| ALPHARMA INC (ALO) Delisted | 10%+ Owner | 419,170 | — | — | -$916.3K | 1 | 2008-08-20 |
| CHINDEX INTERNATIONAL INC (CHDX) Delisted | 10%+ Owner | — | — | — | $0 | 1 | 2008-01-14 |
| CYTOGEN CORP (CYTO) Delisted | 10%+ Owner | 61 | $0.30 | $18 | $774.7K | 7 | 2007-12-19 |
Recent Filings
24 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-10-24 | SKYQ | — | — | $0 | EDGAR |
| 2019-10-28 | — | Buy (P) | — | $0 | |
| 2019-09-27 | — | Buy (P) | — | $0 | |
| 2008-10-10 | CANDELA CORP /DE/ (CLZR) Delisted | Sell (S) | −1,510,000 | -$1.60M | EDGAR |
| 2008-10-06 | CANDELA CORP /DE/ (CLZR) Delisted | Sell (S) | −264,000 | -$508.7K | EDGAR |
| 2008-08-20 | ALPHARMA INC (ALO) Delisted | Sell (S) | −38,000 | -$916.3K | EDGAR |
| 2008-05-12 | — | Other (J) | −4,919,000 | -$3.05M | |
| 2008-01-14 | CHINDEX INTERNATIONAL INC (CHDX) Delisted | Other (J) | — | $0 | EDGAR |
| 2007-12-19 | CYTOGEN CORP (CYTO) Delisted | Buy (P) | +54,000 | $27.0K | EDGAR |
| 2007-12-14 | CYTOGEN CORP (CYTO) Delisted | Buy (P) | +141,000 | $75.6K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.